Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies-Reference-Cited by-同舟云学术

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies

Published:2015-07-21 Issue:7 Volume:10 Page:e0132620
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Dandan,Wang Li,Zhu Honghu,Dou Liping,Liu Daihong,Fu Lin,Ma Cong,Ma Xuebin,Yao Yushi,Zhou Lei,Wang Qian,Wang Lijun,Zhao Yu,Jing Yu,Wang Lili,Li Yonghui,Yu Li

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461);JC Byrd;Blood,2002

2. National Comprehensive Cancer Network. Acute myeloid leukemia, Version 1. 2014. http://www.nccn.org/. Accessed January 30. 2014.

3. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461;JC Byrd;J Clin Oncol,2004

4. Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461;CD Bloomfield;Ann Hematol,2004

5. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial;S Suciu;Blood,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia;Hematology/Oncology Clinics of North America;2023-12

2. Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews;International Journal of Clinical Practice;2022-10-07

3. Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes;Leukemia & Lymphoma;2022-08-24

4. Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy;Haematologica;2021-11-11

5. Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing;Bone Marrow Transplantation;2020-12-05